2024 Budget - A Positive Step for Viral Hepatitis
Hepatitis Queensland welcomes the substantial investments in viral hepatitis initiatives in the 2024 federal budget, which represent a significant step towards eliminating hepatitis by 2030.
The Government will provide $126.5 million over two years to extend and expand activities to support the prevention, testing and treatment of bloodborne viruses and sexually transmissible infections.
Funding highlights include:
Hepatitis C
- • $9.9 million to continue and expand the national hepatitis C point-of-care testing program
- • $6.0 million to continue support for hepatitis C projects and reduce transmission
Hepatitis B
- • $7.8 million to develop and pilot hepatitis B projects to reduce transmission
Support for First Nations Health, Rural and Remote Communities
- • $32.3 million to continue support and promote vaccination uptake in First Nations communities
- • $28.6 million to continue support and expand syphilis and sexually transmissible infections in First Nations communities
- • $16.5 million to continue and expand communicable disease molecular point of care testing for First Nations, rural and remote communities
National Strategies
- • $17.5 million to support continued delivery of the national bloodborne viruses and sexually transmissible infections strategies, including culturally safe sexual health services for First Nations peoples
- • $7.9 million to continue funding peak bodies to implement the national bloodborne viruses and sexual transmissible infections strategies
While acknowledging the need for more equitable funding between hepatitis B and C, these commitments mark important progress. Hepatitis Queensland is dedicated to continuing advocacy for comprehensive hepatitis care and prevention.